CN104225382A - 一种治疗暗疮的中药 - Google Patents
一种治疗暗疮的中药 Download PDFInfo
- Publication number
- CN104225382A CN104225382A CN201410369100.1A CN201410369100A CN104225382A CN 104225382 A CN104225382 A CN 104225382A CN 201410369100 A CN201410369100 A CN 201410369100A CN 104225382 A CN104225382 A CN 104225382A
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- chinese medicine
- traditional chinese
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 21
- 206010000496 acne Diseases 0.000 title abstract description 17
- 238000011282 treatment Methods 0.000 title abstract description 10
- 210000000582 semen Anatomy 0.000 claims abstract description 22
- 241000628997 Flos Species 0.000 claims abstract description 16
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 8
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims abstract description 8
- 241001148763 Blechnum Species 0.000 claims abstract description 8
- 241001532589 Trimeresurus stejnegeri Species 0.000 claims abstract description 8
- 229940079593 drug Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 235000008216 herbs Nutrition 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241001093951 Ailanthus altissima Species 0.000 abstract 1
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- 241000202903 Bergenia purpurascens Species 0.000 abstract 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 abstract 1
- 241000218176 Corydalis Species 0.000 abstract 1
- 244000061508 Eriobotrya japonica Species 0.000 abstract 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 abstract 1
- 240000008058 Lilium brownii Species 0.000 abstract 1
- 235000015982 Lilium brownii Nutrition 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 abstract 1
- 240000005319 Sedum acre Species 0.000 abstract 1
- 235000014327 Sedum acre Nutrition 0.000 abstract 1
- 244000261559 Smilax china Species 0.000 abstract 1
- 235000000485 Smilax china Nutrition 0.000 abstract 1
- 240000004922 Vigna radiata Species 0.000 abstract 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 abstract 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 23
- 239000000796 flavoring agent Substances 0.000 description 22
- 235000019634 flavors Nutrition 0.000 description 22
- 230000006870 function Effects 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 238000009835 boiling Methods 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 230000008961 swelling Effects 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 206010040882 skin lesion Diseases 0.000 description 7
- 231100000444 skin lesion Toxicity 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 208000002874 Acne Vulgaris Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 206010033733 Papule Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 206010037888 Rash pustular Diseases 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 208000001780 epistaxis Diseases 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 208000029561 pustule Diseases 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 206010037844 rash Diseases 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 206010011732 Cyst Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 201000005505 Measles Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- 208000031513 cyst Diseases 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 241000186429 Propionibacterium Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- CKMXBZGNNVIXHC-UHFFFAOYSA-L ammonium magnesium phosphate hexahydrate Chemical compound [NH4+].O.O.O.O.O.O.[Mg+2].[O-]P([O-])([O-])=O CKMXBZGNNVIXHC-UHFFFAOYSA-L 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 229910052567 struvite Inorganic materials 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000036828 Device occlusion Diseases 0.000 description 1
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical class OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- -1 antibiotic Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 210000000835 hypertrophic cicatrix Anatomy 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 208000009146 rhinoscleroma Diseases 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药技术领域,特别涉及一种治疗暗疮的中药。该治疗暗疮的中药,其特殊之处在于:主要由以下重量的原料药制成:薄荷1-5份,冰片3-8份,赤芍1-4份,绿豆1-5份,百合2-5份,甘草1-4份,白芷2-4份,昆布2-6份,枇杷1-3份,木通2-6份,葛根1-3份,辛夷2-6份,岩白菜1-4份,牛蒡子2-5份,野菊花2-6份,地丁1-3份,凤眼草1-3份,菝葜1-4份,酸枣仁1-4份,竹叶青1-4份,马牙半支2-4份,乌毛蕨贯众1-2份,薏苡仁2-6份。本发明吸收效果好、疗效显著、对皮肤无副作用,提高了病人的生活质量;不复发,病人可安心服用,总有效率达93%。
Description
技术领域
本发明涉及中药技术领域,特别涉及一种治疗暗疮的中药。
(一) 背景技术
暗疮是毛囊皮脂腺单位的一种慢性炎症性皮肤病,主要好发于青少年,对青少年的心理和社交影响很大,但青春期后往往能自然减轻或痊愈。临床表现以好发于面部的粉刺、丘疹、脓疱、结节等多形性皮损为特点。
暗疮的发生主要与皮脂分泌过多、毛囊皮脂腺导管堵塞、细菌感染和炎症反应等因素密切相关。进入青春期后人体内雄激素特别是睾酮的水平迅速升高,促进皮脂腺发育并产生大量皮脂。同时毛囊皮脂腺导管的角化异常造成导管堵塞,皮脂排出障碍,形成角质栓,即微粉刺。毛囊中多种微生物尤其是暗疮丙酸杆菌大量繁殖,暗疮丙酸杆菌产生的脂酶分解皮脂生成游离脂肪酸,同时趋化炎症细胞和介质,最终诱导并加重炎症反应。
暗疮的非炎症性皮损表现为开放性和闭合性粉刺。闭合性粉刺(又称白头)的典型皮损是约1毫米大小的肤色丘疹,无明显毛囊开口。开放性粉刺(又称黑头)表现为圆顶状丘疹伴显著扩张的毛囊开口。粉刺进一步发展会演变成各种炎症性皮损,表现为炎性丘疹、脓疱、结节和囊肿。炎性丘疹呈红色,直径1~5毫米不等;脓疱大小一致,其中充满了白色脓液;结节直径大于5毫米,触之有硬结和疼痛感;囊肿的位置更深,充满了脓液和血液的混合物。这些皮损还可融合形成大的炎性斑块和窦道等。炎症性皮损消退后常常遗留色素沉着、持久性红斑、凹陷性或肥厚性瘢痕。临床上根据暗疮皮损性质和严重程度将暗疮分为3度、4级:1级(轻度):仅有粉刺;2级(中度):除粉刺外,还有一些炎性丘疹;3级(中度):除粉刺外,还有较多的炎性丘疹或脓疱;4级(重度):除有粉刺、炎性丘疹及脓疱外,还有结节、囊肿或瘢痕。
西医治疗多以采用异维A酸类药物、抗生素、抗雄激素以及糖皮质激素或使用局部外用药物,但这些治疗不够理想,而且长期使用抗生素会引发一定的不良反应;中医由于具有强调整体观念、协调阴阳、表本兼治、毒副作用小等优点,越来越被人们认可。
(二) 发明内容
本发明为了弥补现有技术的不足,提供了一种疗效好、副作用小的治疗暗疮的中药。
本发明是通过如下技术方案实现的:
一种治疗暗疮的中药,其特殊之处在于:主要由以下重量份数的原料制成:
薄荷1-5份,冰片3-8份,赤芍1-4份,绿豆1-5份,百合 2-5份,甘草1-4份,白芷2-4份,昆布2-6份,枇杷1-3份,木通2-6份,葛根1-3份,辛夷2-6份,岩白菜1-4份,牛蒡子2-5份,野菊花2-6份,地丁1-3份,凤眼草1-3份,菝葜1-4份,酸枣仁1-4份,竹叶青1-4份,马牙半支2-4份,乌毛蕨贯众1-2份,薏苡仁2-6份。
下面为本发明中各药材的功能及作用:
薄荷:性味:辛,凉。归经:归肺、肝经。功效主治:宣散风热。清头目,透疹。用于风热感冒,风温初起,头痛,目赤,喉痹,口疮,风疹,麻疹,胸胁胀闷。
冰片:性味:辛、苦,微寒,归经:归心、脾、肺经。功效:开窍醒神,清热止痛。用于热病神昏、痉厥,中风痰厥,气郁暴厥,中恶昏迷,目赤,口疮,咽喉肿痛,耳道流脓。
赤芍:性味:酸苦,凉。归经:入肝、脾经。主治:行瘀,止痛,凉血,消肿。治瘀滞经闭,疝瘕积聚,腹痛,胁痛,衄血,血痢,肠风下血,目赤,痈肿。
绿豆:性味:味甘,凉平,无毒。功效:清热解毒。治痈疽疮肿初起,烫伤,跌扑伤;并解热药及酒食诸毒。
百合: 性味:甘,寒。归经: 归心、肺经。功能主治:养阴润肺,清心安神。用于阴虚久咳,痰中带血,虚烦惊悸,失眠多梦,精神恍惚。
甘草:性味:甘、平。归脾、胃、肺经。用于心气虚,心悸怔忡,脉结代,以及脾胃气虚,倦怠乏力;痈疽疮疡、咽喉肿痛;气喘咳嗽;胃痛、腹痛及腓肠肌挛急疼痛等。
白芷:性味:辛,温。归经:入肺、髀、胃经。功效:祛风,燥湿,消肿,止痛。治头痛,眉棱骨痛,齿痛,鼻渊,寒湿腹痛,肠风痔漏,赤白带下,痈疽疮疡,皮肤燥痒,疥癣。
昆布:性味:咸、寒。归经:归肝、胃、肾经。功效主治:软坚化痰,利水消肿。主治瘿瘤、瘰疬,噎膈,脚气水肿。
枇杷:性味:甘、酸,凉。归经:入脾、肺,兼入肝。功效:润肺,止渴,下气。治肺痿咳嗽吐血,衄血,燥渴,呕逆。
木通:性味:苦,凉。归经:入心、小肠、膀胱经。功能主治:泻火行水,通利血脉。治小便赤涩,淋浊,水肿,胸中烦热,喉痹咽痛,遍身拘痛,妇女经闭,乳汁不通。
葛根:性味:甘、辛,凉。归经:归脾、胃经。功能:解肌退热,生津,透疹,升阳止泻。用于外感发热头痛、项背强痛,口渴,消渴,麻疹不透,热痢,泄泻;高血压颈项强痛。
辛夷:性味:辛,温。归经:归肺、胃经。功能与主治:散风寒,通鼻窍。用于风寒头痛,鼻塞,鼻渊,鼻流浊涕。
岩白菜:性味:甘、微涩,凉。 功能:清热解毒,止血,调经。用于肺结核咳嗽,咯血,吐血,衄血,便血,肠炎,痢疾,功能性子宫出血,白带,月经不调;外用治黄水疮。
牛蒡子:性味:辛、苦、寒;归经:归肺胃经。功能:风热感冒、温病初起;风热或肺热咳嗽、咯痰不畅;咽喉肿痛;斑疹不透;麻疹初期,疹出不畅及风疹瘙痒;疮疡肿毒及痄腮等。生用可润肠通便,热毒咽喉红肿疼痛,兼有热结便秘尤宜。用于热毒疮肿尚未溃者,常与地丁,野菊花等清热解毒药配伍。
野菊花:性味:苦辛,凉;归经:入肺、肝经。功能主治:疏风清热,消肿解毒。治风热感冒,肺炎、白喉,胃肠炎:高血压,疔,痈,口疮,丹毒,湿疹,天泡疮。
地丁:性味:苦,寒;归经:入肝、脾二经。功效主治:清热利湿,解毒消肿。治疔疮,痈肿,瘰疬,黄疸,痢疾,腹泻,目赤,喉痹,毒蛇咬伤。
凤眼草:性味:苦,凉。功能主治:清热利尿,止痛,止血。用于胃痛,便血,尿血;外用治阴道滴虫。
菝葜:性味:甘、酸,平。功能主治:祛风湿,利小便,消肿毒。治关节疼痛,肌肉麻木,泄泻,痢疾,水肿,淋病,疔疮,肿毒,瘰疬,痔疮。
酸枣仁:性味:甘、酸,平。归经:肝、胆、心经。功能与主治:补肝,宁心,敛汗,生津。用于虚烦不眠,惊悸多梦,体虚多汗,津伤口渴。
竹叶青:药性:苦;涩;性凉;小毒,归心经。功能主治:清热解毒;消肿止痛。主急性热病;急性肝炎;风火牙痛;跌打肿痛;痈疮肿毒;烧、烫伤。
马牙半支:性味:酸,凉。功能与主治:清热解毒,止血,利湿。治痈肿,疔疮,吐血,衄血,血崩,带下,瘰疬,黄疸,跌扑损伤。
乌毛蕨贯众:性味:微苦、凉。功能主治:清热解毒,活血止血,驱虫。主治感冒、头痛,腮腺炎,痈肿,跌打损伤,鼻衄,吐血,血崩,带下,肠道寄生虫。
薏苡仁:性味:甘、淡,凉。归经:归脾、胃、肺经。功能主治:健脾渗湿,除痹止泻,清热排浓。用于水肿,脚气,小便不利,湿痹拘挛,脾虚泄泻,肺痈,肠痈;扁平疣。
本发明的配制方法如下:将上述中药用开水浸泡40分钟后煎煮,煎煮时水份超过中药2-5公分,在水沸腾后用文火煎煮30分钟后,过滤倒出药液即可服用,分早中晚,一日三次。
本发明吸收效果好、疗效显著、对皮肤无副作用,提高了病人的生活质量;不复发,病人可安心服用,总有效率达93%。
(三) 具体实施方式
实施例1
将薄荷1克,冰片3克,赤芍1克,绿豆1克,百合 2克,甘草1克,白芷2克,昆布2克,枇杷1克,木通2克,葛根1克,辛夷2克,岩白菜1克,牛蒡子2克,野菊花2克,地丁1克,凤眼草2.5克,菝葜1克,酸枣仁1克,竹叶青1克,马牙半支2克,乌毛蕨贯众1克,薏苡仁2克用开水浸泡40分钟后煎煮,煎煮时水份超过中药2公分,在水沸腾后用文火煎煮30分钟后,过滤倒出药液即可服用,分早中晚,一日三次。
实施例2
将薄荷2克,冰片5克,赤芍2克,绿豆2克,百合 3克,甘草2克,白芷3克,昆布3克,枇杷2克,木通3克,葛根2克,辛夷3克,岩白菜2克,牛蒡子3克,野菊花3克,地丁2克,凤眼草3克,菝葜2克,酸枣仁2克,竹叶青2克,马牙半支3克,乌毛蕨贯众2克,薏苡仁4克用开水浸泡40分钟后煎煮,煎煮时水份超过中药4公分,在水沸腾后用文火煎煮30分钟后,过滤倒出药液即可服用,分早中晚,一日三次。
实施例3
将薄荷4克,冰片6克,赤芍3克,绿豆3克,百合4克,甘草3克,白芷4克,昆布3克,枇杷3克,木通4克,葛根3克,辛夷5克,岩白菜3克,牛蒡子4克,野菊花4克,地丁3克,凤眼草4克,菝葜4克,酸枣仁4克,竹叶青3克,马牙半支4克,乌毛蕨贯众2克,薏苡仁5克用开水浸泡40分钟后煎煮,煎煮时水份超过中药5公分,在水沸腾后用文火煎煮30分钟后,过滤倒出药液即可服用,分早中晚,一日三次。
实施例4
将薄荷5克,冰片8克,赤芍4克,绿豆5克,百合 5克,甘草4克,白芷4克,昆布4克,枇杷3克,木通6克,葛根3克,辛夷6克,岩白菜4克,牛蒡子5克,野菊花6克,地丁3克,凤眼草5克,菝葜4克,酸枣仁4克,竹叶青4克,马牙半支4克,乌毛蕨贯众2克,薏苡仁6克用开水浸泡40分钟后煎煮,煎煮时水份超过中药5公分,在水沸腾后用文火煎煮30分钟后,过滤倒出药液即可服用,分早中晚,一日三次。
临床观察
(1)一般资料
本发明人于2009年至今对167例暗疮患者进行临床观察治疗,年龄14到40岁不等。
(2)诊断标准
严重:病程时间长,数量多,且红肿严重;
较严重:病程时间较长,数量较多,且红肿较严重;
不严重:病程时间不长,数量不多,且红肿不严重;
轻度:病程时间不长,数量不多,且无红肿。
(3)治疗方法:每日一剂,早、中、晚各服一次,7天一个疗程。
(4)疗效评定标准
痊愈:暗疮100%消除,皮肤无其他不良反应;
显效:暗疮80%消除,皮肤无其他不良反应;
有效:暗疮50%消除,皮肤无其他不良反应;
无效:暗疮没有消除。
(5)治疗效果:
临床治愈103例,占62%;显效38例,有效14例,无效12例,总有效率93%。
Claims (1)
1.一种治疗暗疮的中药,其特征在于:主要由以下重量的原料药制成:
薄荷1-5份,冰片3-8份,赤芍1-4份,绿豆1-5份,百合 2-5份,甘草1-4份,白芷2-4份,昆布2-6份,枇杷1-3份,木通2-6份,葛根1-3份,辛夷2-6份,岩白菜1-4份,牛蒡子2-5份,野菊花2-6份,地丁1-3份,凤眼草1-3份,菝葜1-4份,酸枣仁1-4份,竹叶青1-4份,马牙半支2-4份,乌毛蕨贯众1-2份,薏苡仁2-6份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410369100.1A CN104225382A (zh) | 2014-07-30 | 2014-07-30 | 一种治疗暗疮的中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410369100.1A CN104225382A (zh) | 2014-07-30 | 2014-07-30 | 一种治疗暗疮的中药 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104225382A true CN104225382A (zh) | 2014-12-24 |
Family
ID=52214858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410369100.1A Pending CN104225382A (zh) | 2014-07-30 | 2014-07-30 | 一种治疗暗疮的中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104225382A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104367501A (zh) * | 2014-10-25 | 2015-02-25 | 广州丹奇日用化工厂有限公司 | 一种中草药祛痘组合物及其制备方法和应用 |
| CN105233027A (zh) * | 2015-10-19 | 2016-01-13 | 菏泽海诺知识产权服务有限公司 | 一种治疗漏睛疮的中药汤剂 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101584777A (zh) * | 2008-12-08 | 2009-11-25 | 芮育健 | 花粉白芷银花清热解毒治疗痤疮的新方法 |
| CN103566333A (zh) * | 2012-08-02 | 2014-02-12 | 康凤林 | 一种用于消肿止痛的药物组合及其制备方法 |
-
2014
- 2014-07-30 CN CN201410369100.1A patent/CN104225382A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101584777A (zh) * | 2008-12-08 | 2009-11-25 | 芮育健 | 花粉白芷银花清热解毒治疗痤疮的新方法 |
| CN103566333A (zh) * | 2012-08-02 | 2014-02-12 | 康凤林 | 一种用于消肿止痛的药物组合及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 章六滨等: "清热解毒散结汤治疗重症痤疮临床观察", 《中华中医药学刊》 * |
| 苗凌娜: "解毒化瘀凉血法治疗痤疮58例", 《河南中医》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104367501A (zh) * | 2014-10-25 | 2015-02-25 | 广州丹奇日用化工厂有限公司 | 一种中草药祛痘组合物及其制备方法和应用 |
| CN105233027A (zh) * | 2015-10-19 | 2016-01-13 | 菏泽海诺知识产权服务有限公司 | 一种治疗漏睛疮的中药汤剂 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102631413B (zh) | 一种治疗痤疮的中药组合物 | |
| CN102920820A (zh) | 一种治疗慢性结肠炎的中药组合物 | |
| CN105497244A (zh) | 一种临床护理用治疗尿布皮炎的中药组合物及制备方法 | |
| CN105106588A (zh) | 一种有效治疗便秘的中药组合物 | |
| CN101085302B (zh) | 一种外敷治疗乳腺增生的膏剂 | |
| CN102772534B (zh) | 一种用于治疗痔疮的中药膏 | |
| CN102949571B (zh) | 一种治疗慢性骨髓炎的药物 | |
| CN104225382A (zh) | 一种治疗暗疮的中药 | |
| CN104984148A (zh) | 一种临床用中药伤口护理组合物 | |
| CN101129975A (zh) | 一种外敷治疗乳腺增生的中药膏剂 | |
| CN104958581A (zh) | 一种用于治疗毛囊炎的中药制剂及制备方法 | |
| CN104547748A (zh) | 一种痤疮药及制备方法 | |
| CN104288413A (zh) | 一种治疗小儿痢疾的中药组合物、其制备方法、制剂及应用 | |
| CN103417923A (zh) | 一种治疗消化性溃疡的药物 | |
| CN101574510A (zh) | 一种用于治疗血栓闭塞性脉管炎的复方川芎红花汤 | |
| CN106136750A (zh) | 一种治疗痤疮的药枕 | |
| CN105168579A (zh) | 一种可有效治疗肛周湿疹的外用中药液及制备方法 | |
| CN104225569A (zh) | 一种治疗慢性肠炎的中药组合物 | |
| CN104740481A (zh) | 一种治疗功能性子宫出血的中药 | |
| CN103751502B (zh) | 治疗寻常痤疮的中药 | |
| CN104524362A (zh) | 一种治疗青春痘的中药 | |
| CN101564510A (zh) | 一种有效治疗鹅掌风的中药擦剂 | |
| CN101129938A (zh) | 治疗输卵管炎的一种中药制剂 | |
| CN104107374A (zh) | 一种用于治疗宫颈糜烂的中药胶囊及其制备方法 | |
| CN105250807A (zh) | 一种治疗妇科炎症的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141224 |
|
| RJ01 | Rejection of invention patent application after publication |